DNA (NYSE: DNA) Rule 144 shows insider resale notices totaling tens of thousands of shares
Rhea-AI Filing Summary
DNA submitted a Rule 144 notice reporting proposed resales of Class A common stock. The notice lists sale entries by Austin Che on 02/04/2026 (2,200 shares), 03/11/2026 (2,200 shares) and 04/13/2026 (40,893 shares) with proceeds of $262,291.79 shown for the 04/13/2026 entry. The filing also records a restricted stock vesting date of 10/20/2022 and names Fidelity Brokerage Services LLC as a broker on the notice.
Positive
- None.
Negative
- None.
Insights
Routine Rule 144 resale notice listing multiple small-to-moderate seller filings.
The filing is procedural: it lists specific resale entries by an individual seller and a broker. The amounts cited (2,200; 2,200; 40,893 shares) and a proceeds figure ($262,291.79) are explicit in the excerpt and indicate reported resale activity rather than an issuer capital raise.
Key dependencies are transferability conditions tied to the restricted stock vesting date (10/20/2022) and broker routing via Fidelity Brokerage Services LLC. Subsequent SEC filings or trade reports would confirm settlement and any market impact.